U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: June 27 - July 3, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: June 27 - July 3, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 06/28/2021
Location: Virtual
Subject: Updates on COVID-19 and Myocarditis/Pericarditis
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several leaders of the American Academy of Pediatrics

Event Date: 06/28/2021
Location: Virtual
Subject: Drug Information Association (DIA) 2021 Global Annual Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, media, academia, and other registered guests

Event Date: 06/29/2021
Location: Virtual
Subject: Updates on COVID-19 Vaccines and Myocarditis/Pericarditis
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from Vaccinate Your Family, healthcare stakeholder groups, and state and local public health organizations

Event Date: 06/29/2021
Location: Virtual
Subject: The Dr. John G. Bartlett Award Ceremony
FDA Participant/Group: JEFFREY MURRAY; DEBRA BIRNKRANT;
Non FDA Participant/Group: Government, academia, and other invited guests

Event Date: 06/30/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines

Event Date: 07/01/2021
Location: Virtual
Subject: Good Clinical Trials Collaborative Steering Group Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Several Good Clinical Trials Collaborative members

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 07/01/2021
Location: Virtual
Subject: Generic Drug User Fee Act (GDUFA) Negotiations Mid-Cycle Review
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from industry and congressional staff

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 06/29/2021
Location: Virtual
Subject: World Health Organization (WHO) Steering Committee Meeting of the Member State Mechanism on Substandard and Falsified Medical Products
FDA Participant/Group: N/A
Non FDA Participant/Group: WHO Steering Committee of the Member State Mechanism on Falsified and Substandard Medical Products

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/28/2021
Location: Virtual
Subject: National Organization for Rare Disorders Award Ceremony
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the National Organization for Rare Disorders, Rare Impact Award Ceremony

Event Date: 06/30/2021
Location: Virtual
Subject: COVID-19 Vaccines: Regulatory Strategies for Public Health Emergencies Forum
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Drug Information Association (DIA) 2021 Global Annual Meeting

Event Date: 06/30/2021
Location: Virtual
Subject: Johns Hopkins-University of Washington Symposium: COVID-19 and Children, Adolescents and Families; Speaker: What FDA is Requiring for Emergency Use Authorizations (EUA) / Full Approval in Children
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Johns Hopkins-University of Washington symposium: COVID-19 and Children, Adolescents and Families: Impacts, Issues and the Role of Vaccines

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top